212 related articles for article (PubMed ID: 32477934)
1. Extracellular Vesicles From Gastric Cancer Cells Induce PD-L1 Expression on Neutrophils to Suppress T-Cell Immunity.
Shi Y; Zhang J; Mao Z; Jiang H; Liu W; Shi H; Ji R; Xu W; Qian H; Zhang X
Front Oncol; 2020; 10():629. PubMed ID: 32477934
[TBL] [Abstract][Full Text] [Related]
2. Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway.
Wang TT; Zhao YL; Peng LS; Chen N; Chen W; Lv YP; Mao FY; Zhang JY; Cheng P; Teng YS; Fu XL; Yu PW; Guo G; Luo P; Zhuang Y; Zou QM
Gut; 2017 Nov; 66(11):1900-1911. PubMed ID: 28274999
[TBL] [Abstract][Full Text] [Related]
3. Increased intratumoral mast cells foster immune suppression and gastric cancer progression through TNF-α-PD-L1 pathway.
Lv Y; Zhao Y; Wang X; Chen N; Mao F; Teng Y; Wang T; Peng L; Zhang J; Cheng P; Liu Y; Kong H; Chen W; Hao C; Han B; Ma Q; Zou Q; Chen J; Zhuang Y
J Immunother Cancer; 2019 Feb; 7(1):54. PubMed ID: 30808413
[TBL] [Abstract][Full Text] [Related]
4. Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles.
Ricklefs FL; Alayo Q; Krenzlin H; Mahmoud AB; Speranza MC; Nakashima H; Hayes JL; Lee K; Balaj L; Passaro C; Rooj AK; Krasemann S; Carter BS; Chen CC; Steed T; Treiber J; Rodig S; Yang K; Nakano I; Lee H; Weissleder R; Breakefield XO; Godlewski J; Westphal M; Lamszus K; Freeman GJ; Bronisz A; Lawler SE; Chiocca EA
Sci Adv; 2018 Mar; 4(3):eaar2766. PubMed ID: 29532035
[TBL] [Abstract][Full Text] [Related]
5. Tumor-derived exosomes induce N2 polarization of neutrophils to promote gastric cancer cell migration.
Zhang X; Shi H; Yuan X; Jiang P; Qian H; Xu W
Mol Cancer; 2018 Oct; 17(1):146. PubMed ID: 30292233
[TBL] [Abstract][Full Text] [Related]
6. Extracellular vesicles containing PD-L1 contribute to CD8+ T-cell immune suppression and predict poor outcomes in small cell lung cancer.
Dou X; Hua Y; Chen Z; Chao F; Li M
Clin Exp Immunol; 2022 May; 207(3):307-317. PubMed ID: 35553630
[TBL] [Abstract][Full Text] [Related]
7. Tumor-derived extracellular vesicles containing microRNA-1290 promote immune escape of cancer cells through the Grhl2/ZEB1/PD-L1 axis in gastric cancer.
Liang Y; Liu Y; Zhang Q; Zhang H; Du J
Transl Res; 2021 May; 231():102-112. PubMed ID: 33321257
[TBL] [Abstract][Full Text] [Related]
8. GC-Derived EVs Enriched with MicroRNA-675-3p Contribute to the MAPK/PD-L1-Mediated Tumor Immune Escape by Targeting CXXC4.
Li P; Luo X; Xie Y; Li P; Hu F; Chu J; Chen X; Song W; Wang A; Tian G; Gu X
Mol Ther Nucleic Acids; 2020 Dec; 22():615-626. PubMed ID: 33230461
[TBL] [Abstract][Full Text] [Related]
9. The role of extracellular vesicles and PD-L1 in glioblastoma-mediated immunosuppressive monocyte induction.
Himes BT; Peterson TE; de Mooij T; Garcia LMC; Jung MY; Uhm S; Yan D; Tyson J; Jin-Lee HJ; Parney D; Abukhadra Y; Gustafson MP; Dietz AB; Johnson AJ; Dong H; Maus RL; Markovic S; Lucien F; Parney IF
Neuro Oncol; 2020 Jul; 22(7):967-978. PubMed ID: 32080744
[TBL] [Abstract][Full Text] [Related]
10. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
[TBL] [Abstract][Full Text] [Related]
11. Superinduction of immunosuppressive glioblastoma extracellular vesicles by IFN-γ through PD-L1 and IDO1.
Jung MY; Aibaidula A; Brown DA; Himes BT; Cumba Garcia LM; Parney IF
Neurooncol Adv; 2022; 4(1):vdac017. PubMed ID: 35990703
[TBL] [Abstract][Full Text] [Related]
12. Peritumoural neutrophils negatively regulate adaptive immunity via the PD-L1/PD-1 signalling pathway in hepatocellular carcinoma.
He G; Zhang H; Zhou J; Wang B; Chen Y; Kong Y; Xie X; Wang X; Fei R; Wei L; Chen H; Zeng H
J Exp Clin Cancer Res; 2015 Nov; 34():141. PubMed ID: 26581194
[TBL] [Abstract][Full Text] [Related]
13. Preparation of engineered extracellular vesicles with full-length functional PD-1 membrane proteins by baculovirus expression system.
Ishikawa R; Yoshida S; Sawada SI; Sasaki Y; Akiyoshi K
Biochem Biophys Res Commun; 2020 Jun; 526(4):967-972. PubMed ID: 32299612
[TBL] [Abstract][Full Text] [Related]
14. Atorvastatin Enhances the Efficacy of Immune Checkpoint Therapy and Suppresses the Cellular and Extracellular Vesicle PD-L1.
Choe EJ; Lee CH; Bae JH; Park JM; Park SS; Baek MC
Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015287
[TBL] [Abstract][Full Text] [Related]
15. Integrin and PD-1 Ligand Expression on Circulating Extracellular Vesicles in Systemic Inflammatory Response Syndrome and Sepsis.
Kawamoto E; Masui-Ito A; Eguchi A; Soe ZY; Prajuabjinda O; Darkwah S; Park EJ; Imai H; Shimaoka M
Shock; 2019 Jul; 52(1):13-22. PubMed ID: 30036273
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Detection of PD-L1 Protein and mRNA in Tumor Cells and Extracellular Vesicles through a Real-Time qPCR Assay.
Peng W; Sun D; Lu W; Yin S; Ye B; Wang X; Ren Y; Hong Z; Zhu W; Yu P; Xi JJ; Yao B
Anal Chem; 2023 Jul; 95(28):10625-10633. PubMed ID: 37424077
[TBL] [Abstract][Full Text] [Related]
17. Tumor-Infiltrating PD-L1+ Neutrophils Induced by GM-CSF Suppress T Cell Function in Laryngeal Squamous Cell Carcinoma and Predict Unfavorable Prognosis.
Tang D; Zhang D; Heng Y; Zhu XK; Lin HQ; Zhou J; Tao L; Lu LM
J Inflamm Res; 2022; 15():1079-1097. PubMed ID: 35210813
[TBL] [Abstract][Full Text] [Related]
18. Extracellular vesicles from regenerative human cardiac cells act as potent immune modulators by priming monocytes.
Beez CM; Haag M; Klein O; Van Linthout S; Sittinger M; Seifert M
J Nanobiotechnology; 2019 May; 17(1):72. PubMed ID: 31133024
[TBL] [Abstract][Full Text] [Related]
19. Tristetraprolin Overexpression in Gastric Cancer Cells Suppresses PD-L1 Expression and Inhibits Tumor Progression by Enhancing Antitumor Immunity.
Guo J; Qu H; Shan T; Chen Y; Chen Y; Xia J
Mol Cells; 2018 Jul; 41(7):653-664. PubMed ID: 29936792
[TBL] [Abstract][Full Text] [Related]
20. STAT3 Activity Promotes Programmed-Death Ligand 1 Expression and Suppresses Immune Responses in Breast Cancer.
Zerdes I; Wallerius M; Sifakis EG; Wallmann T; Betts S; Bartish M; Tsesmetzis N; Tobin NP; Coucoravas C; Bergh J; Rassidakis GZ; Rolny C; Foukakis T
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31581535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
